These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26694825)

  • 21. Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology.
    Jeong WK; Kang HJ; Choi SH; Park MS; Yu MH; Kim B; You MW; Lim S; Cho YS; Lee MW; Hwang JA; Lee JY; Kim JH; Joo I; Bae JS; Kim SY; Chung YE; Kim DH; Lee JM
    Korean J Radiol; 2023 Jun; 24(6):482-497. PubMed ID: 37271203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
    Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
    Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
    Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
    J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study on the inconsistency of arterial phase hypervascularity detection between contrast-enhanced ultrasound using sonazoid and gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid magnetic resonance imaging of hepatocellular carcinoma lesions.
    Wang F; Numata K; Chuma M; Miwa H; Moriya S; Ogushi K; Okada M; Otani M; Inayama Y; Maeda S
    J Med Ultrason (2001); 2021 Apr; 48(2):215-224. PubMed ID: 33721130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact.
    Mitsunori Y; Tanaka S; Nakamura N; Ban D; Irie T; Noguchi N; Kudo A; Iijima H; Arii S
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):234-42. PubMed ID: 22399158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of hepatocellular carcinoma cell proliferation by short hairpin RNA of frizzled 2 with Sonazoid-enhanced irradiation.
    Tomizawa M; Shinozaki F; Motoyoshi Y; Sugiyama T; Yamamoto S; Ishige N
    Int J Oncol; 2016 Jan; 48(1):123-9. PubMed ID: 26648389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer.
    Mishima M; Toh U; Iwakuma N; Takenaka M; Furukawa M; Akagi Y
    Breast Cancer; 2016 Mar; 23(2):231-41. PubMed ID: 25143060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography.
    Tanaka H; Iijima H; Higashiura A; Yoh K; Ishii A; Takashima T; Sakai Y; Aizawa N; Iwata K; Ikeda N; Iwata Y; Enomoto H; Saito M; Imanishi H; Hirota S; Fujimoto J; Nishiguchi S
    J Gastroenterol; 2014 Apr; 49(4):755-63. PubMed ID: 23720089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma.
    Hatanaka K; Chung H; Kudo M; Haji S; Minami Y; Maekawa K; Hayaishi S; Nagai T; Takita M; Kudo K; Ueda T; Tatsumi C; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Ueshima K
    Oncology; 2010 Jul; 78 Suppl 1():53-9. PubMed ID: 20616585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
    Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
    J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
    Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
    J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced ultrasonography: a recent application for the diagnosis and treatment of hepatocellular carcinoma.
    Maruyama K; Yoshikawa M; Yokosuka O
    JNMA J Nepal Med Assoc; 2008; 47(171):156-66. PubMed ID: 19079385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced ultrasound techniques for guiding and assessing response to locoregional treatments for hepatocellular carcinoma.
    Andreana L; Kudo M; Hatanaka K; Chung H; Minami Y; Maekawa K; Ruggiero G
    Oncology; 2010 Jul; 78 Suppl 1():68-77. PubMed ID: 20616587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study.
    Shiozawa K; Watanabe M; Kikuchi Y; Kudo T; Maruyama K; Sumino Y
    World J Gastroenterol; 2012 Oct; 18(40):5753-8. PubMed ID: 23155317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions.
    Eso Y; Takai A; Takeda H; Matsumoto T; Lee M; Inuzuka T; Takahashi K; Ueda Y; Marusawa H; Seno H
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1462-1467. PubMed ID: 27623001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
    Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y;
    Oncology; 2014; 87 Suppl 1():7-21. PubMed ID: 25427729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT.
    Hatanaka K; Kudo M; Minami Y; Maekawa K
    Oncology; 2008; 75 Suppl 1():42-7. PubMed ID: 19092271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging.
    Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
    J Ultrasound Med; 2015 Mar; 34(3):411-21. PubMed ID: 25715362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.